Aims To estimate the level of alcohol consumption behaviors in adult survivors of childhood cancer and to test associations between alcohol consumption behaviors and symptoms of neurocognitive impairment and emotional distress. Measurements Survivor report of alcohol use included age at drinking initiation and quantity and frequency of alcohol consumption. Neurocognition was assessed using the CCSS Neurocognitive Questionnaire. Emotional distress symptoms were measured using the Brief Symptoms Inventory-18 and the Posttraumatic Stress Diagnostic Scale. Findings After adjustment for childhood cancer treatment exposures, including cranial radiation therapy, drinking initiation prior to 18 years of age was associated with 30% increased risk of subsequent memory problems [risk ratio (RR) = 1.3; 95% confidence interval (CI) = 1.1-1.5]. Younger age at drinking initiation was associated with future risk of depression (RR = 1.3; 95% CI = 1.1-1.5), anxiety (RR = 1.6; 95% CI = 1.3-2.1), and somatization (RR = 1.2; 95% CI = 1.1-1.4). Persistent heavy/risky drinking was associated with 80% increased risk of persistent psychological distress (RR = 1.8, 95% CI = 1.4-2.3). Conclusions Drinking initiation during adolescence is associated with modest increased risk for memory impairment and emotional distress in adult survivors of childhood cancer.
INTRODUCTION
It is well established that survivors of childhood cancer are at risk of developing neurocognitive morbidities that persist into adulthood [1] [2] [3] [4] [5] [6] . Cancer-specific risk factors include disease involvement of the central nervous system (CNS) and/or treatment with neurotoxic agents (i.e. cranial radiation, antimetabolite chemotherapy) or neurosurgical procedures, particularly when these treatments occur at a young age [7] . Importantly, cancer survivors also are susceptible to factors that affect cognition in the general population, including aging [8, 9] , chronic health conditions [10] [11] [12] and life-style factors such as physical activity [13, 14] , sleep [15] and alcohol use [16] . It remains to be determined whether these life-style factors have a differential impact on survivor cognitive functioning, given their potential vulnerability following exposure to neurotoxic cancer-directed therapies.
In the Childhood Cancer Survivor Study (CCSS) cohort, 16% of adult survivors reported risky drinking and 8% reported heavy drinking at their baseline evaluation [17] . While the longitudinal trajectory of these drinking patterns has not yet been reported, heavy drinking and chronic alcohol use are strongly associated with neurocognitive impairment in non-cancer adult populations [18] . These impairments include difficulties with memory, attention, processing speed, executive functions and visuospatial abilities [19] [20] [21] . In addition to the observed effects on performance-based neurocognitive tasks, patterns of brain activation as well as reduced gray and white matter volumes have been associated with heavy alcohol use [22, 23] . Moreover, individuals who have sustained traumatic brain injuries appear to have increased sensitivity to the effects of alcohol [24, 25] . As childhood cancer survivors who received neurotoxic cancer treatments such as cranial radiation may have sustained diffuse cerebral injury, they also may have increased sensitivity to the effects of alcohol on cognitive processes. However, to date, the impact of chronic, ongoing risky or heavy drinking on neurocognitive function has not been evaluated in aging adult survivors of childhood cancer.
Beyond potential adverse effects on cognition, alcohol consumption has been implicated in the emergence, persistence and worsening of mental health conditions such as depression and anxiety [26] . Up to 40% of adults in the general population who seek treatment for alcohol use disorders have at least one independent mood disorder [27] , and approximately 20% have an alcohol-induced mood or anxiety disorder. Results from a 25-year longitudinal study suggest a causal pathway from alcohol abuse or dependence to major depression [28] , although other studies have suggested reciprocal causation [26] .
Given survivors' risk for treatment-induced neurocognitive impairment, the identification of modifiable life-style factors that may exacerbate or mitigate such deficits is important for informing the selection and/or development of cognitive intervention strategies. Moreover, understanding associations between health behaviors, such as alcohol consumption, and psychological health has the potential to similarly inform mental health interventions for this population. Therefore, the aims of the current study were to (1) estimate the level of alcohol consumption behaviors in adult survivors of childhood cancer, (2) compare alcohol consumption behaviors between survivors and a randomly selected sample of sibling controls, (3) test associations between alcohol consumption behaviors and neurocognitive impairment in survivors and (4) test associations between alcohol consumption behaviors and symptoms of emotional distress in survivors.
METHODS

Design
The CCSS is a multi-institutional retrospective cohort study with longitudinal follow-up of survivors of childhood cancer recruited from 26 institutions across North America, including the United States and Canada. The institutional review board at each participating institution approved the CCSS protocol, and all participants provided informed consent. Medical record abstraction is performed for primary diagnosis, chemotherapy, radiation therapy and surgical procedures. Survivors complete comprehensive surveys reporting on demographics, health-care utilization, health outcomes, health behaviors and psychosocial outcomes. A detailed description of the cohort methodology and study design has been reported previously [29, 30] .
Participants
The CCSS cohort consists of survivors diagnosed with childhood cancer before age 21 between 1 January 1970 and 31 December 1986 who survived for at least 5 years after their primary cancer diagnosis. The sibling comparison cohort was recruited from among a randomly selected subset of survivors. Survivors were eligible for the current analysis if they were at least 18 years of age at baseline and completed the baseline, follow-up 2, and follow-up 4 surveys, which included questions related to alcohol consumption (see Figure 1) . The final study sample included 4484 survivors and 1651 siblings; however, the analysis samples for multivariable models varied slightly based on the missing data for specific predictors and outcomes.
Outcomes
Neurocognitive functioning was measured using the CCSS Neurocognitive Questionnaire (CCSS-NCQ) [31] , a 25-item questionnaire that provides a three-point Likert scale (0 = never a problem to 2 = often a problem) for self-rating of neurocognitive problems. The CCSS-NCQ is comprised of four primary factors: task efficiency, emotion regulation, organization and memory. The CCSS-NCQ was only administered at follow-up 2. Consistent with previous CCSS reports, impairment was defined as a score falling above the 90th percentile based on values obtained in the sibling cohort.
Emotional distress was measured by the Brief Symptom Inventory-18 (BSI) [32] and the Post-traumatic Stress Diagnostic Scale (PDS) [33] . The BSI includes subscales of anxiety, depression and somatization. Using sex-specific normative data, distress on the BSI was defined as a T-score of 63 or greater (equivalent to distress in the highest 10% of the normative sample). Persistent/increasing emotional distress was defined as previously reported [34] , and longitudinally persisting distress (T-score ≥ 63 at baseline, follow-up 2 and follow-up 4) and/or increasing emotional distress (non-significant distress at baseline (T-score < 63) that increased at follow-up 2 or follow-up 4) for any of the three BSI subscales (depression, anxiety, somatization). The PDS is a 17-item measure of diagnostic symptom criteria listed in the Diagnostic and Statistical Manual for Psychiatric Disorders, 4th edition (DSM-IV) [35] . Consistent with prior CCSS reports, a positive endorsement of PTSS was defined by the report of at least one reexperiencing symptom, at least three avoidance symptoms and at least two arousal symptoms, with or without functional impairment [36, 37] .
Predictors
Consistent with past CCSS reports [17, 38] and the National Institute for Alcohol Abuse and Alcoholism (NIAAA), risky drinking was defined as more than four drinks per day or 14 drinks per week for men and more than three drinks per day or seven drinks per week for women [39] . Heavy drinking was defined as six or more drinks per day for men and five or more drinks per day for women at least once per month. Persistent heavy/risky drinking was defined as heavy and/or risky drinking at baseline and at follow-up 4. Age at drinking initiation referred to the year that the participant reported having their first drink on the baseline survey, and was dichotomized as < 18 or ≥ 18 years of age.
Covariates
For models including neurocognitive outcomes, covariates included age at follow-up 2 (NCQ data completion), sex, age at diagnosis, physical health (poor/fair versus good/very good/excellent) and cancer-related pain (none, small amount versus medium amount, a lot, very bad/excruciating), which were ascertained at follow-up 2. Neurocognitive models were stratified by cranial radiation therapy (CRT) exposure (yes versus no). In the CRT model, radiation dose was included per 10 Gy. In the non-CRT model, intravenous methotrexate dose per 100 g/m 2 and number of intrathecal injections were considered. For emotional distress models, covariates included age at follow-up 2, sex, race, age at diagnosis, educational attainment (≤ high school; post-high school training; ≥ college graduate), employment (unemployed; caring for family; part-time; full-time), cancer-related pain and physical health status. Emotional distress models were adjusted for radiation exposure [none, non-cranial and CRT (≤ 20 Gy, > 20 Gy)].
Statistical analysis
Demographic, diagnosis, treatment and health-related characteristics of participants and non-evaluable participants were compared using t-tests and χ 2 tests, and descriptive statistics were calculated for all exposure, covariate and outcome variables. Associations between alcohol consumption and neurocognitive function and relative risks (RR) and corresponding 95% confidence intervals (CI) were estimated using Poisson regression modeling with robust error variance to account for potentially correlated observations [40, 41] . Because CRT and sex have been associated with both alcohol use and neurocognitive impairment in adult survivors of childhood cancer, we examined potential interaction effects. To examine the associations between alcohol consumption and emotional distress symptoms, RRs and corresponding 95% CIs were estimated using the same modified Poisson models as described above. All multivariable models were adjusted for a minimally sufficient set of covariates to reduce confounding bias. A Bonferroni correction was applied to multivariable models. For neurocognitive models with four primary outcomes, P ≤ 0.0125 was considered Figure 1 Consolidated Standards of Reporting Trials (CONSORT) diagram of study participation statistically significant. For emotional distress models with five primary outcomes P ≤ 0.01 was considered statistically significant. We did not adjust the significance threshold for number of covariates because these were selected a priori and not tested in an exploratory manner [42] . Separate multivariable models were conducted with terms for primary cancer diagnosis included and terms for treatment exposures omitted. Analyses were performed using SAS version 9.4.
RESULTS
Survivors (n = 4484) were a mean [standard deviation] of 10.5 (5.6)] years of age at diagnosis, 27.2 (6.2) years of age at baseline and 24.8 (4.4) years from diagnosis (Table 1) . Thirty per cent of survivors were diagnosed with leukemia, 28% with lymphoma and 10% with a central nervous system tumor. One-third of survivors were treated with cranial irradiation (22% with exposure > 20 Gy).
Alcohol consumption patterns
Compared with siblings, survivors were significantly less likely to report heavy drinking (P = 0.002), risky drinking (P < 0.001), persistent heavy/risky drinking (P < 0.001) and consuming their first drink before 18 years of age (P = 0.002; Table 2 ). Survivors treated with CRT were significantly less likely to report drinking before 18 years of age (P < 0.001), heavy drinking (P < 0.001), risky drinking (P < 0.001) and persistent heavy/risky drinking (P < 0.001) compared to survivors who did not receive CRT (Supporting information, Table S1 ). Females were significantly less likely to reported early drinking initiation (P < 0.001), heavy/risky drinking at baseline (P < 0.001) or persistent heavy/risky drinking (P = 0.001; Supporting information, Table S2 ) compared with males.
Neurocognitive and emotional distress outcomes
Twenty-one per cent of survivors reported impairment in task efficiency, 11% in emotion regulation, 12% in organization skills and 14% in memory (Table 2) . Compared with siblings, survivors reported a higher prevalence of depressive (P < 0.001, somatic (P < 0.001) and post-traumatic stress symptoms (P < 0.001). Thirteen per cent of survivors experienced persistent or increasing distress symptoms characterized by elevated symptoms of depression, anxiety and/or somatization compared to 7% of siblings (P < 0.001). Supporting information, Table S2 shows neurocognitive and emotional distress symptoms by sex. Supporting information, Tables S3 and S4 show the proportion of survivors with impaired neurocognitive function and emotional distress for each alcohol consumption behavior by CRT exposure, respectively.
Alcohol consumption and neurocognitive impairment
Assessment of interaction terms revealed no significant interactions between CRT exposure and alcohol consumption patterns or sex and alcohol consumptions patterns with neurocognitive impairment; therefore, interaction terms were not included in our final models, nor were analyses stratified by CRT or sex. In multivariable models adjusted for treatment exposures, associations between alcohol consumption behaviors and neurocognition largely failed to achieve statistical significance (Table 3) . However, drinking initiation at younger than 18 years of age was associated with a 30% increased risk of memory impairment (P = 0.003). Heavy/risky drinking at baseline and persistent heavy/risky drinking did not confer increased risk of neurocognitive impairment.
Alcohol consumption and emotional distress
In multivariable models adjusted for CRT dose (Table 4) , younger age at drinking initiation (< 18 years) was associated with a 30% increased risk of depression (P = 0.007), 60% anxiety (P < 0.001) and 20% somatization (P = 0.007). Heavy/risky drinking at baseline was associated with a 40% increased risk of persistent/increasing emotional distress (P = 0.008). Persistent heavy/risky drinking was associated with a nearly twofold (80%) increased risk of persistent/increasing emotional distress (P < 0.001).
DISCUSSION
The current study examined the association of alcohol consumption behaviors with neurocognitive and emotional functioning in adult survivors of childhood cancer. Our findings suggest that associations between alcohol consumption and neurocognition are relatively modest. In contrast, alcohol consumption was consistently associated with increased risk of emotional distress symptoms in longterm survivors. Drinking initiation prior to 18 years of age was associated with 30% increased risk of memory impairment. This risk was observed while accounting for the effects of known neurotoxic treatments (i.e. CRT, methotrexate). The effects of heavy drinking on cognition may be especially salient during adolescence, given the continued maturation of the brain during this stage of development. Animal studies have shown decreased neurogenesis in the adolescent forebrain and hippocampus following ethanol exposure [43] . In human adolescents, the prefrontal cortex and hippocampal volumes appear reduced in heavy drinkers. Moreover, longitudinal studies have demonstrated that persistent heavy, chronic alcohol use from adolescence to young adulthood is associated with visuospatial and memory deterioration [44] . It has been previously established that survivors of childhood cancer who initiate alcohol use during adolescence have a twofold increased risk for later heavy drinking compared to siblings who initiate drinking at the same age [17] . Although we did not observe an association between heavy/risky drinking and self-reported memory impairment in our study, we speculate that survivors of childhood cancer who initiate drinking in adolescence may be at increased risk for memory problems due to: (1) increased risk for later heavy drinking and associated neurocognitive morbidities and/or (2) the direct effects of alcohol on brain maturation in a potentially compromised nervous system following exposure to neurotoxic cancer treatments.
We observed consistent associations between alcohol consumption patterns (i.e. younger age at drinking initiation, heavy/risky drinking at baseline, persistent heavy/risky drinking) and increased risk of emotional distress symptoms. Similar associations have been reported in non-cancer populations [45, 46] ; however, causal pathways are often difficult to discern and may be reciprocal. For example, symptoms of depression may lead to alcohol consumption through efforts to manage emotional symptoms (e.g. self-medication). Alternatively, the consumption of alcohol may result in neurochemical changes in the brain resulting in depressive symptoms (i.e. interference with serotonin uptake) [26, 47] . Additional prospective longitudinal studies are necessary to further elucidate these associations in survivors of childhood cancer. Independent of alcohol consumption patterns, survivors who reported cancer-related pain and poor physical health status were significantly more likely to report neurocognitive problems and emotional distress symptoms. For example, poor health status was associated with an approximately twofold increased likelihood of neurocognitive impairment for survivors. This is consistent with data from the general population indicating that health conditions, such as cardiopulmonary disease, are associated with deficits in memory, executive functions and processing speed. Because survivors are at increased risk of developing chronic health conditions, future efforts should aim to more clearly understand the impact of these highly prevalent health morbidities on neurocognitive functioning [48] . Cancer-related pain and poor health also have been associated with distress symptoms in past studies [49] [50] [51] ; however, similar to alcohol consumption patterns, the reciprocal associations between these constructs have not adequately been investigated in survivors.
The findings of the current analysis should be considered in the context of several limitations. First, we relied on self-report of neurocognitive problems, which makes our outcomes vulnerable to misclassification. In addition, recall bias may influence self-report of alcohol consumption behaviors, particularly among survivors with memory problems. Moreover, survivors may not accurately report their drinking behaviors, particularly in the context of a study designed to evaluate health outcomes in survivors of childhood cancer. For example, recent data demonstrate that rates of misclassification of self-reported smoking status among survivors range from 8 to 37% for past and current smokers, respectively [52] . Results of potential misclassification (i.e. under-reporting) may have reduced our ability to detect associations between alcohol use patterns and our outcomes. Results also may be influenced by selection bias and loss to follow-up in our cohort. These factors may limit the external validity of our results. A comparison of evaluable study participants and nonevaluable participants indicated that participants in the current analysis were more likely to be female (52.7 versus 41.3%) and less likely to have a CNS tumor diagnosis (10.1 versus 14.7%) or treatment with cranial radiation (35.4 versus 40.8%; Supporting information, Table S5 ). These differences may have resulted in an underestimation of alcohol consumption in survivors because women, in general, consume less alcohol and are more likely to abstain [17] . In fact, female survivors in our study were less likely to engage in alcohol consumption behaviors than were male survivors, yet they were more likely to report neurocognitive problems. In addition, past CCSS data suggest that survivors who received potentially neurotoxic treatments are less likely to engage in risky/heavy drinking; however, these same survivors are more likely to experience neurocognitive problems in adulthood.
Limitations notwithstanding, our results underscore the importance of considering modifiable life-style factors, such as alcohol consumption, when selecting or implementing interventions to treat psychological late effects. Beyond cognitive and emotional consequences, alcohol consumption has also been associated with oropharyngeal, esophageal, liver and stomach cancers. Screening for engagement in risky health behaviors should begin early in survivorship and survivors should be proactively counseled on the risks of excessive alcohol consumption. Moreover, targeted efforts to prevent survivors from engaging in risky health behaviors, particularly beginning in adolescence, may modify the effects of childhood treatment exposures on neurocognitive and emotional functioning in aging adult survivors.
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Alcohol use by cranial radiation therapy (CRT). 
